Active Ingredient History

  • Now
Lobucavir is an antiviral drug that shows broad-spectrum activity against herpesviruses, hepatitis B and other hepadnaviruses, HIV/AIDS and cytomegalovirus. It initially demonstrated positive results in human clinical trials against hepatitis B with minimal adverse effects but was discontinued from further development following the discovery of increased risk of cancer associated with long-term use in mice. Although this carcinogenic risk is present in other antiviral drugs, such as zidovudine and ganciclovir that have been approved for clinical use, development was halted by Bristol-Myers Squibb, its manufacturer.   Wikipedia

More Chemistry
2-amino-9-(2,3-bis(hydroxymethyl)cyclobutyl)-1,9-dihydro-6h-purin-6-one | 9-(2,3-bis-(hydroxymethyl)-1-cyclobutyl)guanine | bms 180194 | bms-180194 | carbocyclic oxetanocin g | c-oxt-g | cyclobut-g | lobucavir | sq 33054 | sq-33054 | sq 34514 | sq-34,514


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue